Detalhe da pesquisa
1.
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Br J Dermatol
; 190(4): 549-558, 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38006317
2.
The combined immunohistochemical expression of AMBRA1 and SQSTM1 identifies patients with poorly differentiated cutaneous squamous cell carcinoma at risk of metastasis: A proof of concept study.
J Cutan Pathol
; 51(6): 450-458, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38421158
3.
Role of immunosuppression in an antibiotic stewardship intervention and its association with clinical outcomes and antibiotic use: protocol for an observational study (RISC-sepsis).
BMJ Open
; 12(12): e068321, 2022 12 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36600326